pevonedistat (MLN4924) - Takeda
sabatolimab (MBG453) - Novartis
Venclexta (venetoclax) - Roche, AbbVie
eltanexor (KPT-8602) - Karyopharm
Tibsovo (ivosidenib) - Servier
magrolimab (ONO-7913) - Ono Pharmaceutical, Gilead
Idhifa (enasidenib) - BMS, Servier
Vyxeos (cytarabine/daunorubicin liposomal formulation) - Jazz
eprenetapopt (APR-246) - Aprea
http://www.ncbi.nlm.nih.gov/pubmed/41733418
 
Athanasios G Galanopoulos; Christina Papi
 
Feb 24, 2026
 
Prev Next